Skip to main content
SpringerLink
Log in

Helicobacter-pylori-Eradikation zur Prävention von Ulkusblutungen

Helicobacter pylori eradication for prevention of ulcer bleeding

  • Klinische Studien
  • Published:
Die Innere Medizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Joo MK, Park CH, Kim JS et al (2020) Clinical guidelines for drug-related peptic ulcer, 2020 revised edition. Gut Liver 14(6):707–726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Malfertheiner P, Megraud F, Rokkas T, Javier PG, Jyh-Ming L, Schulz C, Gasbarrini A, Hunt RH, Leja M, O’Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM (2022) Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. https://doi.org/10.1136/gutjnl-2022-327745

    Article  PubMed  Google Scholar 

  3. Mo C, Sun G, Lu ML et al (2015) Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol 21(17):5382–5392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sarri GL, Grigg SE, Yeomans ND (2019) Helicobacter pylori and low-dose aspirin ulcer risk: a meta-analysis. J Gastroenterol Hepatol 34(3):517–525. https://doi.org/10.1111/jgh.14539

    Article  CAS  PubMed  Google Scholar 

  5. Venerito M, Schneider C, Costanzo R, Breja R, Röhl F‑W, Malfertheiner P (2018) Contribution of helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors. Aliment Pharmacol Ther 47(11):1464–1471. https://doi.org/10.1111/apt.14652

    Article  CAS  PubMed  Google Scholar 

  6. Hawkey C et al on behalf of the HEAT Trialists (2022) Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. Lancet 400:1597–1606

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik II, LMU München, Marchioninistr. 15, 81377, München, Deutschland

    C. Schulz

  2. Lippetal, Deutschland

    S. Nitschmann

Authors
  1. C. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Schulz.

Ethics declarations

Interessenkonflikt

C. Schulz und S. Nitschmann geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

C. Bokemeyer, Hamburg

M. Hallek, Köln

C. Jacobshagen, Karlsruhe

W. Lehmacher, Köln

U. Müller-Ladner, Bad Nauheim

H. Wedemeyer, Hannover

M. Wehling, Mannheim

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schulz, C., Nitschmann, S. Helicobacter-pylori-Eradikation zur Prävention von Ulkusblutungen. Innere Medizin 64, 506–509 (2023). https://doi.org/10.1007/s00108-023-01493-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-023-01493-2

Search

Navigation